Article Index

biotech stocks

How Social Media Affects the Market

Stock Market Today

Democratic presidential front-runner Hillary Clinton demonstrated exactly how social media affects the market last week when her vitriolic tweet sent the biotech sector into an 8% tailspin.

These days, a post or a picture on social media platforms like Facebook, Instagram, or Twitter can have a massive impact on U.S. markets.

We've got four more memorable examples of times when social media buzz has blown up a stock - or entire markets - for better or for worse...

Biotech ETFs Are Now Discounted for 2016 After Sell-Off

Dow Jone

Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July highs.

And while many investors are taking their money to the sideline, this is actually a great time to invest in biotech ETFs with 2016 in mind.

Here's the biotech ETF we're recommending now...

As Another Sector's Sails Lose Wind, Watch This One Barometer


One by one, the bubbles are bursting...

First it was the commodities bubble that blew up in mid-2014, which caused the collapse of energy and commodity stocks -they are now down between 40-80%.

It also caused the end of the corporate credit bubble in high yield bonds and bank loans over the second half of 2014 and into this year.

Then the Chinese stock market, which had gone parabolic early this year, collapsed, sending global markets into a tailspin this summer.

What Hillary's Pharma Plan Means for Biotech Investors

pharma (2)

Martin Shkreli, CEO of Turing Pharmaceuticals, made news this week when he announced he would raise the price of a medication his company had acquired, Darapim (pyrimethamine), from $13.50 to $750 per pill.

Here's what biotech investors need to know...

Biotech Investing Buff Just Made $1.1 Billion Profit in 8 Months – Here's How

Biotech Investing

With a net worth of $12.6 billion, Patrick Soon-Shiong, MD, is the world's richest doctor, the richest American in the healthcare industry, and the 96th-richest person on the planet in 2015 according to Forbes.

And just in August, the 63-year-old became $1.1 billion richer -- from a move he'd made only eight months prior, according to Bloomberg...

Here's Soon-Shiong's story - plus five ways you can cash in with biotech profits of your own...

A Biotech Stock to Buy with "Nearly Limitless" Profit Potential


Today, we're recommending a biotech stock to buy that Money Morning Biotech Investing Specialist Ernie Tremblay says has a "nearly limitless" profit potential.

It's a medical device company with a revolutionary product that helps restore vision to people suffering from blindness.

Here's the revolutionary technology behind this biotech stock to buy...

Two Tactics for Bigger Biotech Investing Profits


Over the past six months, we've seen the Nasdaq Biotechnology Index, an indicator for the entire sector, take some wild swings up and down, often by as much as 10% from week to week.

That's in stark contrast to the previous half-year, when we experienced a relatively steady upward swell.

This year's unsettling international headlines haven't helped. In just the last few months, we've battled doom-and-gloom sentiment on the debt crisis in Greece, currency manipulation in China, cratering oil prices, the burgeoning debt crisis in Puerto Rico, and the specter of a September rate hike from the Fed.

There is good news: This turbulence isn't insurmountable. And the simple tactics I'm about to share with you could dramatically improve your profits in this choppy market...

Why Trillium (Nasdaq: TRIL) Stock Is a Buy After Earnings


Trillium Therapeutics Inc. (Nasdaq: TRIL) stock has dipped nearly 5% in the last week after the company reported a Q2 earnings loss of $0.80. Analysts had been predicting a loss of $0.75 for the quarter.

In the past three months, TRIL stock has now dipped 16.4%, and the poor earnings report only stoked the fears of nervous investors.

But despite its recent performance, TRIL stock is still one of the best biotech stocks to buy now. All because of this incredible cancer treatment...

How This Biotech Stock Gained Over 3,000% and Trapped Investors

Biotech stock

For biotech stock investors, what happened to Aquanox Pharmaceuticals Inc. (Nasdaq: AQXP) over the past week looked like the ultimate fantasy come true.

After reporting positive results from a mid-stage test for its bladder pain syndrome/interstitial cystitis drug AQX-1125 on Aug. 7, Aquanox stock took off like a rocket. At one point it was up more than 3,000%.

Here's the reason Aquanox stock acted so crazily - and what made it ripe to become a trap for retail investors...

How to Pick the Best Biotech Stocks to Buy in Five Easy Steps

Money Morning

Investors who know how to choose the best biotech stocks to buy can cash in. In the last twelve months alone, the Nasdaq Biotechnology Index ETF has outperformed the broader Nasdaq Composite by 25.5%. And the SPDR S&P Biotech ETF has outperformed the S&P 500 almost sevenfold.

Watch our three-minute video for five easy steps to picking the best biotech stocks to buy...

One of the Top Biotech Stocks to Buy Just Hit the Market

biotech stocks to buy

One of the last week's biggest IPOs, the food allergy company Aimmune Therapeutics Inc. (Nasdaq: AIMT), hit the market on Thursday, Aug. 6, and has already climbed more than 20%.

AIMT's early success underscores one of the best biotech stocks to buy that Money Morning Executive Editor Bill Patalon has been recommending all year.

Food allergies affect tens of millions around the world. And the companies that treat these people offer some of the best profit opportunities among biotech stocks today...

This Bioscience Company Has "Nearly Limitless" Income Potential


Medical device companies can be profit-making machines - one manufacturer of magnetic resonance imaging (MRI) machines and other high-tech products is up more than 250% over the past 12 months, for instance.

Most of them make their living by staying on the leading edge of innovation, producing some of the coolest gadgets you can imagine.

And, even better, they can deliver some of the most impressive gains in the bioscience industry to their shareholders.

The good performance of these manufacturers gives you some idea of the potential we're dealing with here.

Just look at these soaring share prices...

This Cannabis Biotech Leader Helped Us Beat the Market by More Than 620%


Back on March 27, 2014, I recommended that Money Morning Members pick up what I felt was the very best play in the burgeoning cannabis biotech industry.

Today, the shares have done even better than I imagined, which is why I wanted to touch base with you again.

And if you missed this stock last year - no worries. We'll start you now as it continues its run - a run that took off while "popular" medical marijuana stocks cratered.

Here's how we'll do it...

Now's Our Chance to Play This Month's Best IPO

IPO Editor's Note: Normally this intelligence would go to paid-up members of Bill's Private Briefing, but this debut is going to be so big, and the medicine so important, that he wanted to give everyone a chance to tap this $21 billion market. The shares start trading on Thursday, Aug. 6, so there's some time to […]

Read More…

Why Pharmaceutical Stocks Are Crushing the Market [Chart]

Biotech Investing

Pharmaceutical stocks have crushed the broader markets in 2015.

The S&P Pharmaceuticals Select Industry Index has climbed 20.9% year to date. In the last 12 months, the index has climbed 42.5%.

Here's how that compares to the broader markets...

© 2015 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: